Of note, up to 60% of the DS newborns show various types of CHDs, a phenotype associating deregulation of several signaling pathways, including VEGF-A, ciliome, hedgehog, folate, ECM-receptor, purine metabolism, cell cycle and Wnt signaling [29,42,43,44,45]. This evidence concerns the gene VEGFA and Dravet syndrome.